Parathyroid Hormone Receptor Mediates the Anti-Myeloma Effect of Proteasome Inhibitors

Bone - Netherlands
doi 10.1016/j.bone.2013.12.025
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Clinical Use of Proteasome Inhibitors in the Treatment of Multiple Myeloma

Pharmaceuticals
Molecular MedicinePharmaceutical Science
2014English

The Neuroendocrine Functions of the Parathyroid Hormone 2 Receptor

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2012English

Resistance to Proteasome Inhibitors and Other Targeted Therapies in Myeloma

British Journal of Haematology
Hematology
2018English

Proteasome Inhibitors Block Ikaros Degradation by Lenalidomide in Multiple Myeloma

Haematologica
Hematology
2015English

The Parathyroid Hormone/Parathyroid Hormone-Related Peptide Receptor Coordinates Endochondral Bone Development by Directly Controlling Chondrocyte Differentiation

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1998English

Novel Strategies in the Treatment of Multiple Myeloma: From Proteasome Inhibitors to Immunotherapy

Journal of Cell Science & Therapy
2010English

Parathyroid Hormone Mediates Bone Growth Through the Regulation of Osteoblast Proliferation and Differentiation

Bone
EndocrinologyPhysiologyHistologyMetabolismDiabetes
2008English

Internalization Determinants of the Parathyroid Hormone Receptor Differentially Regulate Β-Arrestin/Receptor Association

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2001English

MAFb Protein Confers Intrinsic Resistance to Proteasome Inhibitors in Multiple Myeloma

BMC Cancer
Cancer ResearchOncologyGenetics
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy